Trial Details
UNKNOWNBasic Information
| Clinical ID | c1742 |
|---|---|
| Identifier | NCT05190484 |
| Trial Title | bIosimilar of aDalimumab, an European evAluation |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis|Crohn Disease|Ulcerative Colitis |
| Interventions | - |
Participant Information
| Sponsor | Fresenius Kabi |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2022-04-30 |
|---|---|
| Primary Completion Date | 2023-04-30 |
| Completion Date | 2024-04-30 |